LIQUICHEKTM DIABETES CONTROL. LEVELS 1, 2 AND 3.
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BIO-RAD, S.A.·Registered August 09, 2019LIQUICHEKTM DIABETES CONTROL TIENE UN USO INTENCIONADO COMO MATERIAL VALORADO PARA EL CONTROL DE LA CALIDAD CON EL FIN DE SUPERVISAR LA PRECISIÓN DE LOS PROCEDIMIENTOS DE ANÁLISIS DEL LABORATORIO PARA LOS ANALITOS HEMOGLOBINA Y HEMOGLOBINA A1C. AGENTE DE
LIQUICHEKTM DIABETES CONTROL IS INTENTIONALLY USED AS A VALUED MATERIAL FOR QUALITY CONTROL TO MONITOR THE ACCURACY OF LABORATORY ANALYSIS PROCEDURES FOR HEMOGLOBIN AND HEMOGLOBIN A1C ANALYTES. AGENT OF
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO CONTROL.
- Trade Name (English)
- REACTIVE CONTROL.
- Analysis ID
- 1586R2019 SSA
- Registration Date
- August 09, 2019
- Name (Spanish)
- BIO-RAD, S.A.
- Name (English)
- BIO-RAD, S.A.
Access comprehensive regulatory information for LIQUICHEKTM DIABETES CONTROL. LEVELS 1, 2 AND 3. (LIQUICHEKTM DIABETES CONTROL. LEVELS 1, 2 AND 3.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1586R2019 SSA and manufactured by BIO-RAD, S.A.. The device was registered on August 09, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.